Metabolic Disorder
23
3
5
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
13%
3 trials in Phase 3/4
41%
7 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (23)
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)
Rheopheresis as Adjuvant Treatment of Calciphylaxis
Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication
A Study to Evaluate the Efficacy of OxyjunTM on Cardiac Pumping Capacity as Well as Work Productivity in Individuals With Metabolic Risk.
A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)
Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome
Plant Protein Supplementation Within a Healthy Lifestyle Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease
Evaluation of Arginine in Periodontal and Cardiovascular Disease
Air Pollution and Cardiovascular Disease
Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia